TNXP Stock Soars After Announcing License Deal for TNX-1700
Positive news with regards to a cancer medicine almost always sends the stock of a pharmaceutical company higher, and that is what happened with TNXP stock in Tuesday’s trading session. Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) ... [Read]
Tonix Pharmaceuticals Holding Corp Falls Nearly 70% Today
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced this morning that it would be halting its Phase 3 study of its Tonmya drug, which caused its stock price to drop in dramatic fashion. After its twelve-week trial, ... [Read]